BioMatrix And Highmark Announce Settlement

News provided by

Feb 12, 2019, 14:37 ET

WESTON, Fla. and PITTSBURGH, Feb. 12, 2019 /PRNewswire/ -- BioMatrix Specialty Pharmacy and Highmark, Inc. jointly announced today that they have settled litigation pending between the two companies.

This agreement enables both companies to focus on their respective commitments to providing high quality care for patients with chronic medical conditions. To ensure continuity of care, BioMatrix and Highmark will continue to service patients who live in Pennsylvania, Delaware, and West Virginia.

"We are pleased to have reached this mutual settlement and commend Highmark for its enduring commitment to care for people with hemophilia and other chronic conditions," Nicholas Karalis, BioMatrix's interim COO and founder of Elwyn Pharmacy Group, said. "We look forward to working with Highmark to build a partnership that will drive the best possible outcomes for our mutual patients."

Aaron Bilger, VP Internal & External Communications at Highmark Health said: "We are thankful that, as a result of this agreement, specialty medications BioMatrix provides will be widely available across our network."

About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes:, BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex BioCare.

About Highmark Inc.
Highmark Inc. and its health insurance subsidiaries and affiliates collectively are one of America's largest health insurance organizations and together with its Blue-branded affiliates, collectively comprise the third-largest overall Blue Cross and Blue Shield-affiliated organization in the country based on capital. Highmark Inc. and its affiliates operate health insurance plans in Pennsylvania, Delaware and West Virginia that serve approximately 4.6 million members and hundreds of thousands of additional individuals through the BlueCard^® program. Its diversified businesses serve group customer and individual needs across the United States through dental insurance, vision care and other related businesses. Highmark Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies. For more information, visit www.highmark.com.

Contacts:

For BioMatrix: Tara Marchese, Corporate Director of Marketing, 954-908-7636

For Highmark: Aaron Bilger, VP Media/Communications, 412-544-7826

SOURCE BioMatrix Specialty Pharmacy